Navigation Links
Canadian cold/flu breakthrough remedy undergoes NCI-sponsored trial in leukemia patients
Date:11/17/2008

Cancer patients with their weakened immune systems are particularly vulnerable when the cold and flu season hits. To help, the U.S. National Cancer Institute (NCI) is sponsoring a landmark trial to see whether a unique Canadian cold remedy COLD-FX can help.

The trial will examine whether using the #1 pharmacist recommended cold and flu fighting product in Canada ginseng extract COLD-FX reduces infections in chronic lymphocytic leukemia patients; enabling them to remain healthier to fight their disease. Cancer patients have weakened immune systems to begin with, usually as a result of chemotherapy or radiation.

The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in North Carolina. Wake Forest currently oversees approximately 150 cancer trials and is regarded as one of America's leading cancer research facilities.

The double-blind, placebo-controlled trial, involving 336 patients, was originally planned to include up to 19 U. S research sites. However, in approving the study, the NCI accelerated the process targeting completion over a single cold and flu season. To assist in recruitment, it also opened up its cancer trials support unit network of more than 1,500 cancer research sites across the U.S.

The NCI says on its website that the trial is important because both the cancer and its treatment, "can impair immune system functioning and markedly increase risk of infection, the most common complication" of chronic lymphocytic leukemia. "Two randomized, controlled trials have shown that an extract of North American Ginseng, called CVT-E002 (COLD-FX), can significantly reduce the risk of ARI [acute respiratory infection] in older adults," the website says.

In the battle against respiratory infections, there are few effective and economical treatment options. Apart from COLD-FX, there is no known clinical proven therapy for both prevention
'/>"/>

Contact: Warren Michaels
warren.michaels@cvtechnologies.com
780-432-0022
CV Technologies Inc.
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract
2. U of T professor first Canadian woman to win prestigious international science prize
3. Superbugs on the rise in Canadian hospitals, new Queens study shows
4. Leading Insurer Offers Education on How Supplemental Insurance Can Help Offset Challenging Economic Trends in Canadian Market
5. DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress
6. Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacifics Railroad Acquisition Of DM&E
7. Canadian Brand-Name Infant Formulas No Better than Private-Label Formulas
8. Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA
9. Canadian Company Sued for Defrauding Thousands of U.S. Consumers of Dietary Supplements
10. Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008
11. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...identify those who would benefit from liver surger..., Dec. 1 (HealthDay News) -- A CT scan of liver tu... help predict overall survival after chemotherapy,...tin) to cytotoxic chemotherapy has been shown to i...ctal cancer and to produce better results in patie...
(Date:12/1/2009)... Practitioners of any medical, ...ption are breathing a sigh of relief this week wit.... The application, released over the holiday week...ibe voice recordings to do so quickly and seamless... (PRWEB) December 1, 2009 -- The iPhon...
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNews... global leader in the development and delivery of ...he medical, scientific and academic markets, will ...l Search, our first-to-market cross-platform searc...logy lexicon, based on the American Psychological ...
(Date:12/1/2009)... , FORT LAUDERDALE, Fla., Dec. 1 /PRNewswire/...atient enrollment in the randomized clinical trial...nt (Combo Stent). ,, A prospective, randomized,...aluation of an ablu M inal sirolimus coat ED ...ents at up to 20 sites in Asia, Australia, Europe ...
(Date:12/1/2009)...real, December 1, 2009 A Universit de Montral res...Center on Family Violence and Violence Against Wom...s of pornography on men. "We started our research ...ed pornography. We couldn,t find any," says Simon ...ssor at the School of Social Work. , "The objec...
Breaking Medicine News(10 mins):Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Are the effects of pornography negligible? 2
...ice may be able to stop the geriatric population f...able to maintain their balance. The device is...ke structure that conforms to the footwear and hel...in a diary of the number of falls they have on wea...
...rs say that families can now hang on to their depa...rvation service offered by a US genetic testing co...y-based firm called Orchid Cellmark . Orchid says ...ange of information such as protection against fut...
...vity of a chemical in a specific region of the bra... anorexia nervosa. Anorexia nervosa is an eat...ss that is often brought about by the patient. Poo...fect that can cause disturbance in all the body fu...
...or a metropolis in coping with a terrorist attack ...gency medical services. Yesterday London wit...was still celebrating the successful 2012 Olympics...lance service ”reports of an incident". Within the...
... be the determining factor and may play a more dom...esterol as per recent study. Now we know wh...cholesterol despite eating all the sweets and butt...irs of identical twins in whom one was a vigorous ...
...er is a common condition in India where beetle and...een found that certain bacteria’s excessive presen...h. A report published in the Open Access jo...species of bacteria in the saliva at significantly...
Other Medicine News:Health News:London Emergency Services Receive Wide Appreciation 2Health News:Genes More Important Than Exercise for Bad Cholesterol 2
(Date:12/1/2009)..., GLEN BURNIE, Md., Dec. 1 Sleep S... service provider for home testing and evaluation ...has named Richard Hassett, M.D., as its chief exec...t of Matria Healthcare, during its growth from a $... million industry leader in total population healt...
(Date:12/1/2009)... , TAI,AN, China, Dec. 1 /PRNewswire-A...TC Bulletin Board: CBPO) (Nasdaq: CBPO ) ("China ...lasma-based biopharmaceutical companies in,China, ...oval to list its,common stock on the NASDAQ Global...res to begin trading on the NASDAQ on,Wednesday, D...
(Date:12/1/2009)..., SCHAUMBURG, Ill., Dec. 1 Sagent... pharmaceutical company, today announced the launc... and ceftriaxone for injection, USP. Both are anti...ity against gram-positive and gram-negative bacter...in December to complement the four vial sizes laun...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Curcumin may inhibit nicotine induced activation of head and neck cancers 58834 1Stress fatigue plague patients with allergic rhinitis and obstructive sleep apnea 58832 1Patients with chronic rhinosinusitis have increased incidence of other chronic illnesses 58830 1
...nate FS Reduces the,Risk of Joint Damage and Frequ...Damage, BERKELEY, Calif., Oct. 10 Bayer HealthCa... Administration (FDA) has,approved routine prophyl...combinant) to reduce the frequency of bleeding epi...d 0-16 years with severe hemophilia A with no,pre-...
...ring Hope to Millions,of Children in Need, WASHIN...e are without parental care due to causes such as ...dren,s Villages-USA (SOS-USA) is,observing World O...phans,worldwide., To view the Multimedia News Rel...hildrensvillages/35325/ , SOS Children,s Village ...
Other Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2
Micro Wire Driver
SmartDriver
...stem is a full-function, electric powered system t...ange of surgical applications including Arthroscop... Orthopedic Trauma, Oral and Maxillofacial Surgery... Because it is a complete, standardized and specia...
...nsists of a pistol-grip handpiece available in Pne...nge of couplers that can be used in a variety of o...artDriver XT offers significantly increased torque...river. The Battery SmartDriver XT accepts the full...
Medicine Products: